Differential inhibition of 17α-hydroxylase and 17,20 lyase activities by three novel missense CYP17 mutations identified in patients with P450c17 deficiency
Open accessThe DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Abstract
The microsomal enzyme cytochrome P450c17 is an important regulator of steroidogenesis. The enzyme has two functions: 17alpha-hydroxylase and 17,20-lyase activities. These functions determine the ability of adrenal glands and gonads to synthesize 17alpha-hydroxylated glucocorticoids (17alpha-hydroxylase activity) and/or sex steroids (17,20-lyase activity). Both enzyme functions depend on correct steroid binding, but it was recently shown that isolated lyase deficiency can also be caused by mutations located in the redox partner interaction domain. In this article we present the clinical history and molecular analysis of two patients with combined 17alpha-hydroxylase/17,20-lyase deficiency and four patients with isolated 17,20-lyase deficiency. In these six patients, four missense CYP17 mutations were identified. Two mutations were located in the steroid-binding domain (F114V and D116V), and the other two mutations were found in the redox partner interaction domain (R347C and R347H). We investigated the activity of these mutated proteins by transfection experiments in COS-1 cells using pregnenolone, progesterone, or their hydroxylated products as a substrate and measuring 17alpha-hydroxylase- and 17,20-lyase-dependent metabolites in the medium. The mutations in the steroid-binding domain (F114V and D116V) of P450c17 caused combined, complete (F114V), or partial (D116V) 17alpha-hydroxylase and 17,20-lyase deficiencies, whereas mutations in the redox partner interaction domain (R347C and R347H) displayed less severe 17alpha-hydroxylase deficiency, but complete 17,20-lyase deficiency. These findings are consistent with the clinical data and support the observation that the redox partner interaction domain is essential for normal 17,20-lyase function of P450c17.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Several additional patients have been described with similar mutations, including girls with failure to manifest adrenarche (281).”
From The Molecular Biology, Biochemistry, and Physiology of Human Steroidogenesis and Its Disorders (2011) · cites this paper as [281]
Citations
Cites
A simple salting out procedure for extracting DNA from human nucleated cells
Miller, S. A., Dykes, D. D., & Polesky, H. F. (1988) · Nucleic Acids Research · doi:10.1093/nar/16.3.1215 · Cited by 20,330
Williams Textbook of Endocrinology
(2016) · Elsevier eBooks · doi:10.1016/c2013-0-15980-6 · Cited by 3,711
Cytochrome b 5 Augments the 17,20-Lyase Activity of Human P450c17 without Direct Electron Transfer
Auchus, R. J., Lee, T. C., & Miller, W. L. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.6.3158 · Cited by 541
Zhang, L. H., Rodriguez, H., Ohno, S., & Miller, W. L. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.23.10619 · Cited by 455
Disorders of sex differentiation
Grumbach, M. M. (1992) · Medical Entomology and Zoology · Cited by 402
The genetic and functional basis of isolated 17,20 lyase deficiency
Geller, D. H., Auchus, R. J., Mendonça, B. B., & Miller, W. L. (1997) · Nature Genetics · doi:10.1038/ng1097-201 · Cited by 318 · cited 2×
“Only 2 mutations identified in patients with isolated complete 17,20-lyase deficiency were examined in vitro (Table 1) (14).”
BackgroundKoper, J. W., Stolk, R. P., de Lange, P., Huizenga, N. A. T. M., Molijn, G.-J., Pols, H. A. P., Grobbee, D. E., Karl, M., de Jong, F. H., Brinkmann, A. O., et al. (1997) · Human Genetics · doi:10.1007/s004390050425 · Cited by 235
Self-citationAuchus, R. J., & Miller, W. L. (1999) · Molecular Endocrinology · doi:10.1210/mend.13.7.0326 · Cited by 185
Geller, D. H., Auchus, R. J., & Miller, W. L. (1999) · Molecular Endocrinology · doi:10.1210/mend.13.1.0219 · Cited by 183 · cited 2×
“Coexpression of the R347 and R358 mutants with P450 oxidoreductase did not result in a significant increase in 17,20-lyase activity, but addition of excess cytochrome b5 partially restored 17,20-lyase activity (20).”
BackgroundYanagibashi, K., & Hall, P. F. (1986) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)83930-3 · Cited by 171
Cited by
The Molecular Biology, Biochemistry, and Physiology of Human Steroidogenesis and Its Disorders
Miller, W. L., & Auchus, R. J. (2011) · Endocrine Reviews · doi:10.1210/er.2010-0013 · Cited by 2,458
Human cytochromes P450 in health and disease
Nebert, D. W., Wikvall, K., & Miller, W. L. (2013) · Philosophical Transactions of the Royal Society B: Biological Sciences · doi:10.1098/rstb.2012.0431 · Cited by 505
Steroid 17-hydroxylase and 17,20-lyase deficiencies, genetic and pharmacologic
Auchus, R. J. (2017) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2016.02.002 · Cited by 229
“Boys with ILD are usually ascertained at birth because of impaired virilization [18,22,52], and girls with this condition have been identified as siblings of affected boys [52] or during evaluation of primary amenorrhea without hypertension [53].”
The syndrome of 17,20 lyase deficiency
Miller, W. L. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-2161 · Cited by 143
MECHANISMS IN ENDOCRINOLOGY: Rare defects in adrenal steroidogenesis
Miller, W. L. (2018) · European Journal of Endocrinology · doi:10.1530/eje-18-0279 · Cited by 136
Bisphenol A Disrupts Steroidogenesis in Human H295R Cells
Zhang, X., Chang, H., Wiseman, S., He, Y., Higley, E., Jones, P., Wong, C. K. C., Al-Khedhairy, A., Giesy, J. P., & Hecker, M. (2011) · Toxicological Sciences · doi:10.1093/toxsci/kfr061 · Cited by 134
Sherbet, D. P., Tiosano, D., Kwist, K. M., Hochberg, Z., & Auchus, R. J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m307586200 · Cited by 131
Androgen synthesis in adrenarche
Miller, W. L. (2009) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-008-9102-4 · Cited by 127
“isolated 17,20 lyase deficiency [87, 89].”
Isolated 17,20-lyase deficiency due to the cytochrome b5 mutation W27X
Kok, R. C., Timmerman, M. A., Wolffenbuttel, K. P., Drop, S. L. S., & de Jong, F. H. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-1745 · Cited by 111
“A final point distinguishing the findings in our patient from those in patients with POR or CYP17A1 mutations is the observation that in these patients cortisol levels do not increase after ACTH stimulation (11, 22), whereas in the present patient both basal and ACTH-stimulated cortisol levels were completely normal.”
BackgroundSelf-citationMartin, R. M., Lin, C. J., Costa, E. M. F., de Oliveira, M. L., Carrilho, A., Villar, H., Longui, C. A., & Mendonca, B. B. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030988 · Cited by 109
Idkowiak, J., Randell, T., Dhir, V., Patel, P., Shackleton, C. H. L., Taylor, N. F., Krone, N., & Arlt, W. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-2413 · Cited by 104
Marsh, C. A., & Auchus, R. J. (2014) · Fertility and Sterility · doi:10.1016/j.fertnstert.2013.11.011 · Cited by 103
Beuten, J., Gelfond, J., Franke, J. L., Weldon, K. S., Crandall, A. C., Johnson‐Pais, T. L., Thompson, I. M., & Leach, R. J. (2009) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-09-0076 · Cited by 100
“CYP17 mediates both 17a-hydroxylase and 17,20-lyase activity, and is involved in the biosynthesis of both 17ahydroxylated glucocorticoids and sex steroids (6-8).”
BackgroundPolygenic sex determination in the cichlid fish Astatotilapia burtoni
Roberts, N. B., Juntti, S. A., Coyle, K. P., Dumont, B., Stanley, M. K., Ryan, A. Q., Fernald, R. D., & Roberts, R. B. (2016) · BMC Genomics · doi:10.1186/s12864-016-3177-1 · Cited by 84
“Mutations of CYP17A1 in humans produce low androgen levels and ambiguous or female external genitalia in XY individuals [47].”
BackgroundKim, Y., Kang, M., Choi, J., Lee, B. H., Kim, G.-H., Ohn, J. H., Kim, S. Y., Park, M. S., & Yoo, H. (2013) · Metabolism · doi:10.1016/j.metabol.2013.08.015 · Cited by 84
“E305G) [9,11,12], whereas alterations in the heme-binding site (e.”
BackgroundInfluentialMiller, W. L. (2004) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2004.07.005 · Cited by 82
P450c17 deficiency: clinical and molecular characterization of six patients
Rosa, S., Duff, C., Meyer, M., Lang-Muritano, M., Balercia, G., Boscaro, M., Kemal Topaloglu, A., Mioni, R., Fallo, F., Zuliani, L., et al. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-1486 · Cited by 71
Tiosano, D., Knopf, C., Koren, I., Levanon, N., Hartmann, M. F., Hochberg, Z., & Wudy, S. A. (2008) · European Journal of Endocrinology · doi:10.1530/eje-07-0712 · Cited by 71
The next 150 years of congenital adrenal hyperplasia
Turcu, A. F., & Auchus, R. J. (2015) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2015.05.013 · Cited by 70
Naffin-Olivos, J. L., & Auchus, R. J. (2006) · Biochemistry · doi:10.1021/bi051623y · Cited by 66
Yang, J., Cui, B., Sun, S., Shi, T., Zheng, S., Bi, Y., Liu, J., Zhao, Y., Chen, J., Ning, G., et al. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-2283 · Cited by 63
Salvador, J. A. R., Pinto, R. M. A., & Silvestre, S. (2013) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2013.04.006 · Cited by 82
Congenital adrenal hyperplasia: focus on the molecular basis of 21-hydroxylase deficiency
Gonçalves, J., Friães, A., & Moura, L. (2007) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399407000300 · Cited by 60
Lack of Defects in Androgen Production in Children with Hypospadias
Holmes, N. M., Miller, W. L., & Baskin, L. S. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-032098 · Cited by 63
Bhatt, M. R., Khatri, Y., Rodgers, R. J., & Martin, L. L. (2016) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2016.02.033 · Cited by 63
Rendic, S. P., & Guengerich, F. P. (2018) · Drug Metabolism Reviews · doi:10.1080/03602532.2018.1483401 · Cited by 61
The post-translational regulation of 17,20 lyase activity
Miller, W. L., & Tee, M. K. (2014) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2014.09.010 · Cited by 56
“Subsequent studies found additional patients with R347H and with the similar mutation R347C, which caused an indistinguishable phenotype and also had selective loss of 17,20 lyase activity in vitro (Kate-Booij et al., 2004; VanDenAkker et al., 2002).”
BackgroundPeng, H.-M., Im, S.-C., Pearl, N. M., Turcu, A. F., Rege, J., Waskell, L., & Auchus, R. J. (2016) · Biochemistry · doi:10.1021/acs.biochem.6b00532 · Cited by 50
The Adrenal Cortex and its Disorders
Miller, W. L. (2009) · Brook's Clinical Pediatric Endocrinology · doi:10.1002/9781444316728.ch13 · Cited by 50
A Novel Point Mutation in P450c17 (CYP17) Causing Combined 17α-Hydroxylase/17,20-Lyase Deficiency
Brooke, A. M., Taylor, N., Shepherd, J. H., Gore, M. E., Ahmad, T., Lin, L., Rumsby, G., Papari-Zareei, M., Auchus, R. J., Achermann, J. C., et al. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-2653 · Cited by 53
“R347H and R358Q) that change the distribution of surface charges on the redox binding site of P450c17 impair electron transfer and can result in isolated 17,20-lyase deficiency with preserved 17 hydroxylase function (8, 9, 13).”
BackgroundDhir, V., Reisch, N., Bleicken, C., Lebl, J., Kamrath, C., Schwarz, H., Grötzinger, J., Sippell, W. G., Riepe, F. G., Arlt, W., et al. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-0172 · Cited by 52
Fernández‐Cancio, M., Camats, N., Flück, C. E., Zalewski, A., Dick, B., Frey, B. M., Monné, R., Torán, N., Audí, L., & Pandey, A. V. (2018) · Pharmaceuticals · doi:10.3390/ph11020037 · Cited by 50
“Normal/Elevated Reactive Low normal Hyporeactive 60 0 van den Akker 2002 [29]”
BackgroundInfluentialSwart, A. C., Storbeck, K., & Swart, P. (2010) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2009.12.014 · Cited by 45
Cui, Y.-L., Zheng, Q.-C., Zhang, J.-L., Xue, Q., Wang, Y., & Zhang, H.-X. (2013) · Journal of Chemical Information and Modeling · doi:10.1021/ci400553w · Cited by 41
Diagnosis and Treatment of Disorders of Sexual Development
Rey, R. A., & Josso, N. (2015) · Elsevier eBooks · doi:10.1016/b978-0-323-18907-1.00119-0 · Cited by 40
The hunt for a selective 17,20 lyase inhibitor; learning lessons from nature
Bird, I. M., & Abbott, D. H. (2016) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2016.04.021 · Cited by 48
P450 Enzymes in Steroid Processing
Auchus, R. J., & Miller, W. L. (2015) · Springer eBooks · doi:10.1007/978-3-319-12108-6_12 · Cited by 47
Steroid 17α-Hydroxylase Deficiency—Not Rare Everywhere
Miller, W. L. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031770 · Cited by 40
Nguyen, A. D., Mapes, S. M., Corbin, C. J., & Conley, A. J. (2008) · Journal of Endocrinology · doi:10.1677/joe-08-0337 · Cited by 38
Patócs, A., Likó, I., Varga, I., Gergics, P., Boros, A. M., Fütő, L., Kun, I. Z., Bertalan, R. Á., Tóth, S., Pázmány, T., et al. (2005) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2005.06.035 · Cited by 39
Translating genomics to the clinical diagnosis of disorders/differences of sex development
Parivesh, A., Barseghyan, H., Délot, E. C., & Vilain, E. J. N. (2019) · Current topics in developmental biology/Current Topics in Developmental Biology · doi:10.1016/bs.ctdb.2019.01.005 · Cited by 40
Steroidogenic Enzymes in Leydig Cells
Payne, A. H. (2007) · Humana Press eBooks · doi:10.1007/978-1-59745-453-7_10 · Cited by 39
ten Kate‐Booij, M. J. (2004) · Human Reproduction · doi:10.1093/humrep/deh065 · Cited by 34
“In order to con®rm a genetic disorder, DNA from blood lymphocytes from both the index patient and her mother was analysed for mutations in this gene using methods described previously (Van den Akker et al., 2002).”
BackgroundMethodInfluentialCYP17A1 mutations identified in 17 Chinese patients with 17α-hydroxylase/17,20-lyase deficiency
Yao, F., Huang, S., Kang, X., Zhang, W., Wang, P., & Tian, Q. (2012) · Gynecological Endocrinology · doi:10.3109/09513590.2012.705373 · Cited by 33
“A founder effect has been suggested for the microinsertion of four nucleotides in codon 480 described in Mennonite descendants [15,16], the deletion of a phenylalanine in codon 53 or 54 described in Japanese subjects [17].”
BackgroundInherent steroid 17α,20-lyase activity in defunct cytochrome P450 17A enzymes
Gonzalez, E. R., Johnson, K. M., Pallan, P. S., Phan, T. T. N., Zhang, W., Li, L., Wawrzak, Z., Yoshimoto, F. K., Egli, M., & Guengerich, F. P. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.ra117.000504 · Cited by 32
“Mutation of Arg-369 flips the side chains of Glu-365 and Arg-358 around (the latter of which corresponds to the conserved Arg-347 of human P450 17A1, known to also be critical to lyase function (20)), such that the latter two engage in a salt bridge in the mutant structure.”
BackgroundApparent pregnene hydroxylation deficiency (APHD): seeking the parentage of an orphan metabolome
Shackleton, C. H. L., & Malunowicz, E. (2003) · Steroids · doi:10.1016/s0039-128x(03)00115-6 · Cited by 31
Pattison, J. C., Abbott, D. H., Wendy Saltzman, A., Conley, A. J., & Bird, I. M. (2009) · Journal of Endocrinology · doi:10.1677/joe-08-0554 · Cited by 31
“…is given: membrane (membrane insertion domain); substrate binding (substrate binding domain); redox (POR/CYTB5 binding domain); heme (heme binding domain); NR (not reported) (modified from Biason-Lauber et al. (2000), van den Akker et al. (2002), Martin et al. (2003) and Sherbet et al. (2003)).”
BackgroundThe broad phenotypic spectrum of 17α-hydroxylase/17,20-lyase (CYP17A1) deficiency: a case series
Sun, M., Mueller, J. W., Gilligan, L. C., TAYLOR, A. E. R., Shaheen, F., Noczyńska, A., T'Sjoen, G. G., Denvir, L., Shenoy, S., Fulton, P., et al. (2021) · European Journal of Endocrinology · doi:10.1530/eje-21-0152 · Cited by 31
“A small number of individuals affected by 17OHD present with apparently isolated 17,20-lyase deficiency, with abolished or severely reduced 17,20-lyase activity but only mild to moderate impairment of 17 α -hydroxylase activity (12, 13, 14).”
Miller, W. L. (2012) · Science Signaling · doi:10.1126/scisignal.2003318 · Cited by 36
Deng, F., Xiao, P., Lei, S., Zhang, L., Yang, F., Tang, Z.-H., Liu, P.-Y., Liu, Y., Recker, R. R., & Deng, H. (2007) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.070303 · Cited by 30
The Adrenal Cortex and Its Disorders
Miller, W. L., Achermann, J. C., & Flück, C. E. (2008) · Elsevier eBooks · doi:10.1016/b978-141604090-3.50017-x · Cited by 33
Insights into Interactions of Human Cytochrome P450 17A1: A Review
Singh, H., Kumar, R., Mazumder, A., Salahuddin, S., Mazumder, R., & Abdullah, M. M. (2022) · Current Drug Metabolism · doi:10.2174/1389200223666220401093833 · Cited by 37
Haider, S. M., Patel, J. S., Poojari, C., & Neidle, S. (2010) · Journal of Molecular Biology · doi:10.1016/j.jmb.2010.05.069 · Cited by 27
Han, B., Xue, L., Fan, M., Zhao, S., Liu, W., Zhu, H., Cheng, T., Lu, Y., Cheng, K., Song, H., et al. (2016) · Endocrine · doi:10.1007/s12020-016-0957-y · Cited by 28
Isolated 17,20-lyase (desmolase) deficiency in a 46,XX female presenting with delayed puberty
Şimşek, E., Özdemir, İ., Lin, L., & Achermann, J. C. (2005) · Fertility and Sterility · doi:10.1016/j.fertnstert.2004.11.063 · Cited by 27
17α-Hydroxylase/17,20-Lyase Deficiency in 46,XY: Our Experience and Review of Literature
Maheshwari, M., Arya, S., Lila, A. R., Sarathi, V., Barnabas, R., Rai, K., Bhandare, V. V., Memon, S. S., Karlekar, M. P., Patil, V. A., et al. (2022) · Journal of the Endocrine Society · doi:10.1210/jendso/bvac011 · Cited by 31
“Although a small number of studies have attempted to define complete and partial 17OHD based on clinical phenotype, androgens, and cortisol levels [4], there are no universally accepted definitions for the grading of CYP17A1 deficiency.”
BackgroundZhao, Z., Lü, L., Wang, O., Wu, X., Sun, B., Zhang, W. Y., Wang, X., Mao, J., Chen, S., Tong, A., et al. (2022) · Endocrine · doi:10.1007/s12020-021-02966-w · Cited by 26
Rare forms of congenital adrenal hyperplasia
Tosun, B. G., & Güran, T. (2023) · Clinical Endocrinology · doi:10.1111/cen.15009 · Cited by 28
Polymorphic variants of CYP 17 and CYP 19A and risk of infertility in endometriosis
Szczepańska, M., Wirstlein, P. K., Skrzypczak, J., & Jagodziński, P. P. (2013) · Acta Obstetricia Et Gynecologica Scandinavica · doi:10.1111/aogs.12210 · Cited by 23
“This enzyme carries out both steroid 17a-hydroxylase and 17, 20-lyase biochemical reactions, which are essential activities in androgen biosynthesis in the gonads and adrenal cortex (15).”
BackgroundStructural features and dynamic investigations of the membrane-bound cytochrome P450 17A1
Cui, Y., Xue, Q., Zheng, Q., Zhang, J., Kong, C., Fan, J., & Zhang, H. (2015) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2015.05.017 · Cited by 23
Turan, S., Bereket, A., Güran, T., Akçay, T., Papari-Zareei, M., & Auchus, R. J. (2008) · European Journal of Endocrinology · doi:10.1530/eje-08-0632 · Cited by 21
Mula-Abed, W.-A. S., Pambinezhuth, F., Al-Kindi, M., Busaidi, N. A., Al-Muslahi, H. N., & Al-Lamki, M. A. (2014) · Oman Medical Journal · doi:10.5001/omj.2014.12 · Cited by 23
Paris, F., Gaspari, L., Mbou, F. M., Philibert, P., Audran, F., Morel, Y., Biason‐Lauber, A., & Sultan, C. (2016) · Andrology · doi:10.1111/andr.12145 · Cited by 20
Рубцов, П. М., Nizhnik, A. N., Dedov, I. I., Kalinchenko, N. Y., Petrov, V., Orekhova, A., Spirin, P., Prassolov, V., & Tiulpakov, A. N. (2015) · European Journal of Endocrinology · doi:10.1530/eje-14-0834 · Cited by 20
“lyase activity was comparable with the results for P342T and R496H mutations associated with 222 similar clinical manifestation of CYP17A1 deficiency (4-5, 8).”
BackgroundResultInfluentialNovel P450c17 Mutation H373D Causing Combined 17α-Hydroxylase/17,20-Lyase Deficiency
Sahakitrungruang, T., Tee, M. K., Speiser, P., & Miller, W. L. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-0645 · Cited by 21
Successful Delivery in 17,20-Lyase Deficiency
Blumenfeld, Z., & Koren, I. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab222 · Cited by 19
Application of the New Classification on Patients with a Disorder of Sex Development in Indonesia
Juniarto, A. Z., van der Zwan, Y. G., Santosa, A., Hersmus, R., de Jong, F. H., Olmer, R., Bruggenwirth, H. T., Themmen, A. P. N., Wolffenbuttel, K. P., Looijenga, L. H. J., et al. (2012) · International Journal of Endocrinology · doi:10.1155/2012/237084 · Cited by 16
Self-citationLeung, M. T., Cheung, H. N., Iu, Y. P. H., Choi, C. H., Tiu, S. C., & Shek, C. C. (2019) · Journal of the Endocrine Society · doi:10.1210/jendso/bvz016 · Cited by 18
Chernoff, M., Lin, T., Demanelis, K., Griend, D. J. V., Ahsan, H., & Pierce, B. L. (2020) · Toxicological Sciences · doi:10.1093/toxsci/kfaa075 · Cited by 19
Hydrohysteroid Dehydrogenases – Biological Role and Clinical Importance – Review
Atanassova, N. N., & Koev, Y. (2012) · InTech eBooks · doi:10.5772/54149 · Cited by 23
Türkkahraman, D., Güran, T., Ivison, H. E., Griffin, A., Vijzelaar, R., & Krone, N. P. (2015) · Sexual Development · doi:10.1159/000375183 · Cited by 15
“Normal renin concentrations in hypertensive patients and low renin concentrations in normotensive patients have been described [Van Den Akker et al., 2002; Müssig et al., 2005].”
BackgroundFriedelin, a novel inhibitor of CYP17A1 in prostate cancer from Cassia tora
Joshi, B., Bhandare, V. V., Vankawala, M., Patel, P., Patel, R. K., Vyas, B., & Krishnamurthy, R. (2022) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2022.2145497 · Cited by 18
“…deficiencies of 17alpha-hydroxylase and 17,20-lyase, whereas mutations in the redox partner interaction domain (R347C, R347H, and R358Q) resulted in isolated 17alpha-hydroxylase deficiency, but complete 17,20-lyase deficiency (Geller et al., 1999; Gupta et al., 2001; Van Den Akker et al., 2002).”
BackgroundZhang, D., Yao, F., Luo, M., Wang, Y., Tian, T., Deng, S., & Tian, Q. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.978026 · Cited by 13
“6% and <1% residual activities of 17a-hydroxylase and 17,20-lyase, respectively (15).”
BackgroundNájera, N., Garibay-Nieto, N., Pastrana, Y., Lara, I. P., Peña, Y. R., Duran, J. P., Coyote, N., Hidalgo, A., Kofman‐Alfaro, S., & Queipo, G. (2009) · Endocrine Pathology · doi:10.1007/s12022-009-9088-9 · Cited by 15
Schwab, K. O., Moisan, A. M., Homoki, J., Peter, M., & Simard, J. (2005) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem.2005.18.4.403 · Cited by 13
Yang, W., Li, H., Wang, S., Huang, R., Zhang, Y., Guo, M., Huang, L., Li, S., Yang, R., Zhao, D., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-62044-x · Cited by 10
Genetic Aspects of Gender Identity Development and Gender Dysphoria
Klink, D. T., & den Heijer, M. (2013) · Focus on sexuality research · doi:10.1007/978-1-4614-7441-8_2 · Cited by 17
“This enzyme mediates both 17-alphahydroxylase and 17,20-lyase activity and allows the adrenal glands and gonads to synthesize both 17-alpha-hydroxylated glucocorticoids (via 17-alpha-hydroxylase activity) and sex steroids (via 17,20-lyase activity) (Chung et al., 1987 ; Kagimoto, Winter, Kagimoto, Simpson, & Waterman,…”
BackgroundA rare cause of delayed puberty and primary amenorrhea: 17α-hydroxylase enzyme deficiency
Beştaş, A., Bolu, S., Ünal, E., Karakaya, A. A., Eröz, R., Tekin, M., & Haspolat, Y. K. (2021) · Endocrine · doi:10.1007/s12020-021-02914-8 · Cited by 14
Neres, M. S., Auchus, R. J., Shackleton, C. H. L., & Kater, C. E. (2010) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/s0004-27302010000900009 · Cited by 10
“The disease is caused by mutations in the CYP17A1 gene which encodes cytochrome P450c17, an enzyme expressed in the adrenal cortex and the gonads displaying both 17α-hydroxylase and 17,20-lyase activities, among others (4-12).”
BackgroundUrinary steroid profiling: a powerful method for the diagnosis of abnormal steroidogenesis
Koyama, Y., Homma, K., & Hasegawa, T. (2014) · Expert Review of Endocrinology & Metabolism · doi:10.1586/17446651.2014.904199 · Cited by 9
“Some mutations have been reported to cause apparently isolated 17,20-lyase deficiency [36,37], which is characterized by significantly increased B metabolites/Anetiocholanolone (Et) ratio, whereas slightly increased or normal pregnanediol (PD)/20aPT ratio and B/F metabolites ratio.”
BackgroundAthanasoulia, A. P., Auer, M. K., Riepe, F. G., & Stalla, G. K. (2013) · Sexual Development · doi:10.1159/000348301 · Cited by 11
“Van Den Akker EL, Koper JW, Boehmer AL, Themmen AP, Verhoef-Post M, et al: Differential inhibition of 17alpha-hydroxylase and 17,20-lyase activities by three novel missense CYP17 mutations identified in patients with P450c17 deficiency.”
BackgroundDiagnosis and Treatment of Disorders of Sexual Development
Rey, R. A., Josso, N., & Forest, M. G. (2010) · Elsevier eBooks · doi:10.1016/b978-1-4160-5583-9.00119-2 · Cited by 6
Ünal, E., Yıldırım, R., Taş, F. F., Tekin, S., Ceylaner, S., & Haspolat, Y. K. (2019) · Gynecological Endocrinology · doi:10.1080/09513590.2019.1707798 · Cited by 7
Steroidal CYP17 Inhibitors for Prostate Cancer Treatment: From Concept to Clinic
Salvador, J. A. R., Vania, M., & Silvestre, S. (2013) · InTech eBooks · doi:10.5772/52290 · Cited by 10
“b5) [44-48], the phosphorylation of serine/threonine residues [44, 49-51], and single amino acid mutations [52-55].”
BackgroundCamats, N., Üstyol, A., Atabek, M. E., Dick, B., & Flück, C. E. (2015) · Clinical Case Reports · doi:10.1002/ccr3.343 · Cited by 10
Chen, H., Chen, Y., Mao, H., Huang, H., & Lou, X. (2023) · Blood Pressure · doi:10.1080/08037051.2023.2195008 · Cited by 7
Genetic Deficiencies of Cytochrome P450c17 (CYP17A1)
Auchus, R. J. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-416006-4.00009-0 · Cited by 6
Cannarella, R., Condorelli, R. A., Gusmano, C., Garofalo, V., Aversa, A., Calogero, A. E., & Vignera, S. L. (2023) · Fertility and Sterility · doi:10.1016/j.fertnstert.2023.09.013 · Cited by 9
A novel mutation in CYP17A1 gene leads to congenital adrenal hyperplasia: A case report
Nazari, M., Mehrjardi, M. Y. V., Neghab, N., Aghabagheri, M., & Ghasemi, N. (2019) · International Journal of Reproductive BioMedicine (IJRM) · doi:10.18502/ijrm.v17i6.4817 · Cited by 6
“The genetics, pathophysiologx, and management of human deficiencies of P450c17.”
BackgroundInfluentialSuccessful live birth in women with partial 17α-hydroxylase deficiency: report of two cases
Du, X., Jia, Q., Wu, S., Wang, B., & Guan, Y. (2024) · Reproductive BioMedicine Online · doi:10.1016/j.rbmo.2024.103855 · Cited by 6
Flück, C. E. (2011) · Advances in experimental medicine and biology · doi:10.1007/978-1-4419-8002-1_1 · Cited by 5
Ueda, Y., Usui, T., Watanabe, T., Kaneko, K., Nakatani, R., Kakita‐Kobayashi, M., Tanase‐Nakao, K., Nanba, K., Tsuiki, M., Tagami, T., et al. (2015) · AACE Clinical Case Reports · doi:10.4158/ep14388.cr · Cited by 5
Yamagata, S., Kageyama, K., Usui, T., Saito, K., Takayasu, S., Usutani, M., Terui, K., & Daimon, M. (2021) · Endocrine Journal · doi:10.1507/endocrj.ej21-0266 · Cited by 7
Saltarelli, M. A., Ferrante, R., Marcello, F. D., David, D., Valentinuzzi, S., Pilenzi, L., Federici, L., Rossi, C., Stuppia, L., & Tumini, S. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph19116880 · Cited by 5
“Our patient’s mutation was previously reported in a male patient suffering from genital ambiguity, who, however, presented a homozygous mutation at this site, as well as in other patients with compound heterozygous mutations of CYP17A1 [18,19].”
BackgroundCongenital adrenal hyperplasia and hypertension
Tosun, B. G., & Güran, T. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-96120-2.00015-7 · Cited by 6
The Principles, Enzymes, and Pathways of Human Steroidogenesis
Auchus, R. J., & Miller, W. L. (2010) · Elsevier eBooks · doi:10.1016/b978-1-4160-5583-9.00096-4 · Cited by 6
Bilyalova, A., Bilyalov, A. I., Filatov, N. S., Shagimardanova, E. I., Kiyasov, A. P., Vorontsova, M. V., & Gusev, O. (2024) · Laboratory Animal Research · doi:10.1186/s42826-024-00212-8 · Cited by 6
A steroid metabolomic approach to 17α-hydroxylase/17,20 lyase deficiency
Tiosano, D., Navon, R., Flor, O., Knopf, C., Hartmann, M. F., Wudy, S. A., Yakhini, Z., & Hochberg, Z. (2010) · Metabolomics · doi:10.1007/s11306-010-0217-8 · Cited by 4
“However, this result was at odds with a subnormal level of stimulated cortisol expressed during an ACTH test as it was found in other patients with mutations, such as R347H and R358Q, that cause isolated 17, 20 lyase deficiency (Van Den Akker et al. 2002; Geller et al. 1999).”
BackgroundResultGao, H., Xu, J., Ma, Q., Tang, F., Ga, Q., Li, Y., Guan, W., Ge, R.-L., & Yang, Y.-Z. (2022) · International Journal of General Medicine · doi:10.2147/ijgm.s345495 · Cited by 4
“(17α-hydroxylase activity) and/or sex steroids (17, 20-lyase activity).(33) Various disease susceptibility variants ofCYP17A1”
BackgroundAlbu, A. I., Iancu, M. E., & Albu, D. N. (2023) · Life · doi:10.3390/life13040921 · Cited by 3
Metadata
- Authors
- van den Akker, E. L. T., Koper, J. W., Boehmer, A. L. M., Themmen, A. P. N., Verhoef-Post, M., Timmerman, M. A., Otten, B. J., Drop, S. L. S., & De Jong, F. H.
- Affiliations
- Erasmus MC (NL)
- Radboud University Medical Center (NL)
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2002-12
- Volume
- 87
- Issue
- 12
- Pages
- 5714-5721
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2126123126
- Cited by
- 125
- References
- 31
- Citations by year
- 2026: 2 · 2025: 3 · 2024: 5 · 2023: 7 · 2022: 8 · 2021: 4 · 2020: 1 · 2019: 5 · 2018: 3 · 2017: 3 · 2016: 8 · 2015: 9 · 2014: 5 · 2013: 9 · 2012: 4
- FWCI
- 1.51
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- RePub (Erasmus University Rotterdam) (submittedVersion, other-oa)
- EUR Research Repository (Erasmus University Rotterdam) (submittedVersion, other-oa)
- Radboud Repository (Radboud University) (submittedVersion)
- RePub (Erasmus University Rotterdam) (submittedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Sexual Differentiation and Disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal Regulation and Hypertension
- Keywords
- P450c17, missense mutations, 17-hydroxylase deficiency, 17,20-lyase deficiency, steroidogenesis, steroid-binding domain, glucocorticoid synthesis, sex steroid synthesis, enzyme activity
- MeSH terms
- Adolescent, Animals, Child, Female, Humans, Male, Metabolism, Inborn Errors, Middle Aged, Oxidation-Reduction, Steroid 17-alpha-Hydroxylase, Steroids, COS Cells, Mutation, Missense
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.